Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.


NDAQ:HSDT - Post by User

Comment by MrEvilxon Jan 22, 2019 5:06pm
96 Views
Post# 29266981

RE:RE:RE:Absolute Rubbish!

RE:RE:RE:Absolute Rubbish!I don't understand why any of these posts are weird ? It was a top pick very recently on BNN, that got me interested. But now it is down quite a bit in just a few days. I don't talk to the CEO as you claim in your posts. Neither do I know the scientists as you claim you have talked to. I have read your posts on this board, you claim many things but, most of them are just the info you somehow know without any supporting proof. I don't want to discredit your posts and analysis or work here. I can dissect your posts too, but I dont want to, I expect you should think before calling someone weird. It's a cause of concern when someone totally uproots the theory of the product. GLTA Longs.
prokofiev wrote:
You're a weird poster, suddently showing up this am as the short report hits the tape and most of your comments having a negative tone to them, or repeating parts of it, or questionning how long you should hold on to it. 
 
"This is not good at all for the Helius"
"not sure how long to hold onto this stock?"
"I think Jayrus4's is right, this is causing more shorts"
 
First off, the product got approved by Health Canada. Not sure how many instances exist where a medical device was approved by Health Canada and not the FDA.
 
Secondly, the product works. All the patients in the study had plateaued after physical therapy. This means that whatever small improvement they were able to get following their brain injury, had stopped increasing. How can the improvement in the trial then be entirely associated with physical therapy as the short report claims? The improvements achieved by the patients in the study, based on the SOT, are significantly higher on average than what physical therapy can do on its own. I  have personally spoken to scientists and therapists that are extremely excited about the potential of this device having seen it help patients they have known for years.
 
Maybe this too is fake?  https://vimeo.com/181665292
 
Prokofiev


MrEvilx wrote: HSDT is my relatively new position, seems to be dropping everyday, not just today...

the very thing short report targets is the legitimacy of the product. they say the product doesn't work.. 

not sure how long to hold onto this stock ?

GLTA

ShakesPeer wrote: The last ditch efforts of the scoundrels! Great company and more importantly wonderful product that will change lives. Not one relative piece of ‘information’ in that release. 






Bullboard Posts